Single Point Partners, LLC Eli Lilly & CO Transaction History

Single Point Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $15,842 - $18,605	51 Added 3.98%	1,331 $457,000
Q4 2022 Jan 10, 2023	BUY	$321.55 - $374.67 $6,431 - $7,493	20 Added 1.59%	1,280 $468,000
Q3 2022 Oct 07, 2022	BUY	$296.48 - $337.87 $10,376 - $11,825	35 Added 2.86%	1,260 $408,000
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $44,596 - $52,363	160 Added 15.02%	1,225 $397,000
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $72,519 - $90,122	309 Added 40.87%	1,065 $305,000
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $169,986 - $210,954	756 New	756 $209,000
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $231,793 - $285,254	-1,046 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $51,637 - $66,792	-286 Reduced 21.47%	1,046 $240,000
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $218,874 - $283,343	1,332 New	1,332 $247,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Single Point Partners, LLC with notifications on news.